We analyzed gene expression in neurons from 16 cases divided into four groups, ie, human immunodeficiency virus (HIV)-associated dementia (HAD)/HIV encephalitis (HAD/ HIVE), HAD alone, HIVE alone, and HIV positive alone. We produced the neurons using laser capture microdissection from cryopreserved basal ganglia (specifically globus pallidus). Gene expression in pooled neurons from each case was analyzed on GE CodeLink Microarray chips with 55,000 gene fragments per chip. One-way analysis of variance showed significant changes in expression of 197 genes among the four groups (P , 0.005). The three groups, ie, HAD/HIVE, HAD alone, and HIVE alone, were compared with the HIV-positive group using Fisher's least significant difference test, and associated gene expression changes were assigned to each of the three comparisons. Identified genes were associated with 159 functional categories and many of the genes had more than one function. The functional groups included adhesion,
Introduction
The term "NeuroAIDS" has been used generally to describe the involvement of the central nervous system in human immunodeficiency virus (HIV)-related disease. The neurodegenerative processes in HIV infection result in neurocognitive decline, which range in severity from asymptomatic neurocognitive impairment to minor neurocognitive disorder and to HIV-associated dementia (HAD). There have been changes in the definitions during the last decade that evolved to the current term used for these conditions, ie, HIV-associated neurocognitive disorders (HAND). The precise pathogenesis of neurodegeneration associated with HIV infection is still unclear. However, neurons are the final targets of the neurodegenerative process, and additional cells are involved as well. The concomitant damaged substrate exhibits brain inflammation that is associated with HIV infection, ie, HIV encephalitis (HIVE), and can also involve macrophage/microglial infiltration and astrocytosis. [1] [2] [3] [4] [5] Although
In related work, IFN-γ showed increased expression in brain tissue from patients who died with NeuroAIDS and drug abuse compared with controls, while other cytokines did not show elevation. 21 In another study, gene expression in gray matter from the frontal lobe was analyzed using microarrays comparing cases with HIVE versus control cases without HIVE. This study indicated that HIV-1 infection in brain tissue associated with HIVE resulted in neurodegeneration and interfered with genes that regulate the cytoskeleton, synaptic-dendritic integrity and function, and signaling, and induced a neuroinflammatory response. Seventy-four genes were downregulated and 59 genes were upregulated. Downregulated genes had functions related to signaling (phosphatidylinositol-3-kinase, Ras-Raf-MEK1), transcription, cytoskeleton (MAP-1B, MAP-2, tubulin, adducin-2), the cell cycle (p35, p39, CDC-L2, CDC42, PAK1), synaptic plasticity, and synaptic transmission (ion channels, synaptogyrin, synapsin II). Upregulated genes had functions related to signaling modulation (MEK3, EphB1), cytoskeleton (myosin, aduccin-3, radixin, and dystrobrevin), transcription (STAT1, OLIG2, Pax-6), neuroimmune response (immunoglobulin G, major histocompatibility complex, β 2 -microglobulin) and antiviral response (interferon inducible). 22 Gene expression profiles related to astrocytes were shown to have many similarities across differing brain tissues (from patients with HIV-1 dementia and from macaques infected with simian immunodeficiency virus) and included several human and murine astrocyte cell culture systems. The use of astrocyte culture systems in the study of NeuroAIDS is supported because of the similarity of gene expression profiles in brain tissue and cultured cells and because astrocytes constitute a large percentage of cells in brain tissue. Several in vitro studies utilized HIV-1 and HIV-1 proteins, ie, Tat, envelope glycoprotein gp120, or negative regulatory factor. The correspondence of gene expression perturbed in these systems and in the brain includes cytokines, chemokines, and their receptors, and is also consistent with astrocyte activation. 23, 24 Neuronal cell cultures are also model systems. For example, a neuronal culture model of the dysfunctional NeuroAIDS brain including drug abuse utilized eight treatment conditions (2 × 2 × 2), with and without each of cocaine, Tat, and envelope protein. Statistically significant perturbation of gene expression was demonstrated for 35 genes across all treatment conditions using one-way analysis of variance. Functions of these genes included signaling, immune-related functioning, and transcription control. 25 Human brain cortex middle frontal gyrus gene expression profiles were compared for cases of HAD or milder cognitive dysfunction versus HIV-negative cases. This work focused on neuronal dysfunction and possible relationships with subcortical dementia. Genes studied were ionic conductance carriers that control membrane excitation. Overexpressed genes included calcium-driven K + channel, leak type of K + channel, adenosine receptor, serotonin receptor, and the gamma aminobutyric acid receptor subunit. Underexpressed genes included two voltage-gated K + channels, a Na + channel subunit, a neuronal type of voltage-sensitive Ca 2+ channel, a metabotropic glutamate receptor, and the N-methyl-D-aspartic acid receptor subunit. Although unfractionated tissue was used, the perturbed gene expression was considered to stem from neurons because changed expression of these genes changes did not occur in gyral white matter and were not associated with overall changes in glial markers. Moreover, these changes occurred with HAD, with and without HIVE, and were not associated with increased inflammatory gene expression. 26, 27 The Trojan horse model predicts that HIV-1-infected monocytes are a risk for brain penetration of HIV-1 via monocyte trafficking into the brain. 28 Surface gene expression associated with such cells included CD14, CD68, CD14a, and HLA-DR. 29 Pulliam et al studied gene expression on CD14+ monocytes from HIV-infected cases. Cases with high virus load showed increased expression of sialoadhesin, CD16, CCR5, and MCP-1. However, proinflammatory cytokine gene expression (interleukin-1, interleukin-6, and tumor necrosis factor-α) was unchanged. 30 Microarray analysis in a monkey model using frontal lobe tissue from simian immunodeficiency virus-infected brains identified 98 genes with altered expression. Genes expressed were associated with promoting macrophage entry into the brain and associated toxic products. Those significantly upregulated included proteins in infiltrating macrophages, endothelial cells, and resident glia (eg, CD163, Glut5, and ISG15). Proteins found in cortical neurons included cyclin D3, tissue transglutaminase, α1-antichymotrypsin, and STAT1. 31 Laser capture microdissection has been used successfully in the study of several human brain diseases, including the HIV-1-infected brain, subacute sclerosing panencephalitis, Parkinson's disease, and Huntington's disease. [32] [33] [34] [35] [36] [37] [38] [39] In the current study, only cases with HAD and HIVE (as well as HIV-1-positive controls) were used. Thus, work in NeuroAIDS has progressed to the point where cell-specific studies will be able to elucidate additional information using novel approaches. We report on gene expression in specific neuroanatomically defined neurons.
Materials and methods

Brain tissue
As previously described, 39 autopsied cryopreserved brain tissue was obtained from the National Institutes of Health-sponsored National NeuroAIDS Tissue Consortium sites 40, 41 (Table 1) . At each of the National NeuroAIDS Tissue Consortium sites, the diagnosis of HIV-1-positive individuals with and without HAD and HIVE was made based on premortem neurological and clinical neuropsychological examination of the patients and at postmortem by neuropathological examination. Each subject was given a diagnosis, using a standardized, algorithmic diagnostic worksheet to combine neurological, neuropsychological, functional, and laboratory information. Postmortem tissues were examined by board-certified neuropathologists to exclude subjects with opportunistic central nervous system infections, tumors, or other causes of dementia, such as Alzheimer's disease. Furthermore, most subjects were below the age at which a dementing neurodegenerative illness would be expected. 7, 8, [11] [12] [13] 42 Tissue was dissected from the globus pallidus and embedded in optimal cutting temperature compound. Sections 10 microns thick were cut using a cryostat at −23°C. The cryosections were mounted on laser capture microdissection slides (Microoptics of Florida, Palm Beach, FL). Prior to laser capture microdissection, the slides were cryopreserved at −80°C in sealed Bakelite slide boxes containing drierite. 
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Laser capture microdissection
Slides for laser capture microdissection were lightly stained with Nissl (Arcturus Inc, Mountain View, CA) and dehydrated using an ethanol series followed by xylenes as previously described. 39 A Leica laser microdissection microscope (Leica Corporation, Bannockburn, IL) was used for laser capture microdissection using standardized settings and the laser beam precisely followed the neuron's outer membrane. Only neurons with nucleoli were microdissected. No other cells had nucleoli. 39 
RNA purification
For each case and control tissue, batches of 200 microdissected single cell neurons were suspended in 20 µL of extraction buffer (Picopure RNA extraction kit, Arcturus Inc) and RNA was extracted. The batches were pooled from multiple cryosections of each tissue. A CapSure-ExtractureSure assembly incubation block with cover (Arcturus Inc) was used to house the tubes. The block was incubated for 30 minutes at 42°C to extract the RNA. The RNA was cryofrozen on dry ice and stored under liquid nitrogen. 39 
gene expression analysis
Biotin-labeled cRNA was prepared by linear amplification of the poly (A)+ RNA population within the total RNA sample. Briefly, about 0.5 ng of total RNA (estimated by the number of cryosectioned cells used for RNA isolation) was amplified using a RiboAmp HS kit (Arcturus). After second-strand cDNA synthesis and purification of double-stranded cDNA, in vitro transcription was performed using T7 RNA polymerase in the presence of biotinylated uridine-5′-triphosphate. It must be noted as crucial in the method, that the quantity and quality of the cRNA were assayed by spectrophotometry followed by analysis on an Agilent Bioanalyzer (Agilent Technologies, Colorado Springs, CO). The quality of the cRNA is paramount to ensure nonbiased representation of labeled transcripts containing the complement of the probe sequences deposited on the array. 39 Ten micrograms of purified cRNA were fragmented to uniform size and applied to CodeLink Human Whole Genome Bioarrays (GE Healthcare, manufacturer instructions) in hybridization buffer. The specifications, use, and descriptions of the GenUS BIOSYSTEMS CodeLink human CHIPS were as described previously. 43, 44 CodeLink Human Whole Genome arrays comprise approximately 55,000 30-mer probes designed to probe conserved exons across the transcripts of targeted genes. These probes represent annotated, full length, and partial human gene sequences from major public databases.
All fragmented samples were visualized on the Agilent Bioanalyzer to verify complete fragmentation to about 0.1 kb size before array analysis. Arrays were hybridized at 37°C for 18 hours in a shaking incubator, washed in 0.75 × tris sodium chloride EDTA (TNE) at 46°C for 1 hour, and stained for 30 minutes with Cy5-streptavidin dye conjugate. Arrays were then rinsed, dried, and scanned at 5 µm resolution with a GenePix™ 4000B scanner (Axon Instruments, according to manufacturer instructions and software).
Statistical analysis Data production
CodeLink Expression Analysis software (GE Healthcare) was used to process the scanned images from arrays (gridding and feature intensity) and the data generated for each feature on the array were analyzed using GeneSpring software (Agilent Technologies). All control genes and genes that did not pass the quality control metrics of the manufacturer were removed from further analysis. 44 To compare individual expression values across arrays, raw intensity data from each gene were normalized to the median intensity of the array. Only genes with values greater than background intensity in at least one treatment condition were used for further analysis. Using a ratio interpretation of the data and normalization of each gene to the median intensity across conditions, data were filtered by expression intensity for genes that did not vary by 50% across all samples within the experiment. These unchanging genes were also eliminated from further analysis. This set of present genes was filtered for genes that were within one standard deviation from the mean of replicates. The remaining qualified gene list was queried for genes in treated groups that had ratios .2.0 and ,0.5 (two-fold changes) relative to controls. Gene identification based on the GE identifiers was further accomplished using standard websites. [43] [44] [45] [46] 
Statistical methods
The data from this two-way unbalanced cross-classification experiment were analyzed first using analysis of variance to find genes that were statistically significantly different among the four groups at P # 0.005. Following the analysis of variance, pairwise Student t-tests were performed using the mean square error from the analysis of variance to test the simple effects of (HAD 
Pathway analysis
Pathway figures and gene interactions were generated using Gene Network Central PRO. 47 Pathways were also analyzed using Ariadne Pathways Assist. 48 
Results
gene expression changes
Sixteen globus pallidus specimens were used as a single experiment ( Table 1 ). The means and standard errors of 197 genes are shown in Table 2 . Of these genes, 150 were identified from the GE CodeLink, NCBI, and GeneCards websites. + showed 65 genes upregulated and 33 genes downregulated. In all three comparisons, three genes showed simultaneous upregulation and three genes showed simultaneous downregulation. In addition, comparing HAD/HIVE, HAD alone, and HIVE alone versus HIV + , the following gene expression shifts, respectively, were one up-up-down, updown-up, down-up-up, up-down-down, two down-down-up, and three down-up-down ( Table 2) . The triply regulated genes were as follows: up-up-up, B3GALT1 (galactose transferase), FLJ14167 (potassium inwardly-rectifying channel), and an unidentified gene; up-up-down, NYD-SP26 (development), up-down-up, SLC44A5 (choline transporter-like protein 5), down-up-up, one gene unidentified; down-down-down, HoxD11/HoxD10 (transcription factor, homeobox-regulated development), TBC1D22A (GTPase activator); downdown-up, one gene unidentified, HNRPA1P5 (heterogeneous nuclear ribonucleoprotein A1 pseudogene 5); down-up-down, one gene unidentified, DNAJC3 (chaperone, interferoninduced, double-stranded RNA-activated protein kinase inhibitor), SLAMF6 (SLAM family member 6, CD2 surface receptor, membrane component); and up-down-down, SLC36A4 (amino acid transporter).
gene expression groups
The identified genes and their functions are shown in Table 3 Inward rectifier potassium channels allow potassium to flow into the cell rather than out of it. As external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. Inward rectification is due to blockage of outward current by internal magnesium. Can be blocked by extracellular barium and cesium. The inward rectifier potassium channel family (also known as 2-TM channels) include the strong inward rectifier channels (KIR2.x), the G protein-activated inward rectifier channels (KIR3.x) and the ATPsensitive channels (KIr6.x, which combine with sulfonylurea receptors). Structurally, the poreforming subunit of KIr channels is the alpha subunit. It contains a single pore domain between two membrane-spanning regions. Four alpha subunits combine to form a tetramer, with the pore domain of each subunit contributing to the structure of the central pore. Pathways Figure 1 illustrates typical pathways and connections among seven select genes. The seven genes are APOB, NECAB3 (APBA2BP), GRIA3, IAPP, HOXD10, UBE2K, and NELL1. Gene functions are shown in Table 3 . The seven genes and their interconnected related pathways are: APOB, IAPP, and NECAB3 (Apba2BP), the beta-amyloid pathway; HOXD10 and UBE2K, the ubiquitination pathway; GRIA3, other glutamate receptors; and NELL1, signaling and amyloid production. These seven genes are interconnected via genes (inserted by the GenePro program) in overlapping pathways that broadly include signaling, transcription, amyloid, and ubiquitination pathways. Similarly, interconnections and pathways may be produced for the other 143 genes in Table 3 , that are too numerous and complex to show in one figure.
Discussion
Of the 197 genes that showed significant expression changes in HAD/HIVE, HAD alone, HIVE alone, versus HIV + , 150 genes were identified. These genes were members of 159 groups and functions. It is beyond the scope of this article to analyze the genes in detail and the ramifications of the disease state within which gene expression varied significantly. The groups and functions, within which the genes fall, overlap many of the cellular processes in neurons. Although several of these cellular processes may not be considered neuron-specific, they are most likely expressed as part of the stress and attempt-atrecovery processes that the neurons exhibit in HAD/HIVE, HAD, and HIVE, compared with the control HIV + . Broadly, the categories (with some descriptors) include adhesion (intercellular interactions), amyloid (implicated in damage to cognition in Alzheimer's disease), apoptosis (neuronal dysfunction and cell death, also certainly associated with the end state of loss of cognition), binding (of various metal and biochemical ions, crucial in cellular processes), channel complexes (components of ion transport within cells and the plasma membrane), cell cycle (attempts 
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HAD/HIVe neuron gene expression by the cell to expel noxious molecules through shutdown or traversing the cell division cycle), chaperone (assisting proteins to attain and maintain functional conformations), chromatin (central in transcription, genome maintenance and repair, and epigenetics), cytokines (inflammation), cytoskeleton, filaments, and matrix (scaffolding and intracellular transport), diGeorge syndrome (genes involved in brain development), and Huntington's disease (trinucleotide repeats that result in gene dysfunction), metabolism (breakdown of biochemical and cell components), mitochondria (energy production for the cell and also proteins needed for mitochondrion function and survival), multinetwork detection protein or RNA (proteins or RNAs that are involved in multiple different molecular pathways and networks), sensory perception (in this study, visual-related and olfactoryrelated protein expression was perturbed), receptor (binding that is required prior to an effect being exerted, signaling, by proteins and solutes), ribosome and tRNA (key elements in protein synthesis), noncoding miRNA (a novel realm in the control of gene expression), signaling (intracellular and extracellular molecular pathways), splicing (transcription), synapse (crucial in neuron function), transcription factor (proteins involved in initiation and process of transcription), transport (intracellular and intercellular movement of proteins and ionic and nonionic solutes), multidrug resistance (a process by which cells become resistant to drugs by shutting down their transport), and ubiquitin cycle (protein turnover). In addition, it should be noted that the ubiquitin pathway marks proteins for metabolism and degradation, whereas chaperones assist proteins to attain their optimal functional states. 26, 49 We hypothesize the existence of multinetwork detection proteins and RNAs. Such proteins and RNAs would be involved in multiple unrelated molecular pathways and networks. This is consequently different from proteins that are involved in multiple, but related, pathways or homeobox transcription genes of development. For green, upregulation of function and transcription; gray, regulation exists but direction unknown as yet; beige, gene products directly interact; dotted light blue, predicted protein-protein interaction; and purple, correlated expression detected by microarray experiments. 46 The seven genes are selected as representative of pathways including signaling, transcription, amyloid, and ubiquitination. example, MYO9A may be a multinetwork detection protein because it interacts with myosin filaments and actin-based motor molecules involved in intracellular movement, has ATPase activity, and regulates rho activity, integrin binding, proteolysis, cell adhesion, and central nervous system development. 45, 46 Potentially devastating effects for neuronal function and survival could result from gene expression changes in beta-amyloid-like protein and amyloid beta-A4 precursor protein binding family A member 2 binding protein. The effects of the former may be due to its amyloid-like properties and the effects of the latter, changes that may occur in amyloid precursor protein metabolism and signaling, due to changes in the receptor protein expression. In addition, changes in apolipoprotein B expression could be associated with dementia in NeuroAIDS as it is in Alzheimer's disease. 50 Severe changes in gene expression are anticipated, due to the stress that results from chronic HIV-1 infection of the brain. Accordingly, expression of glycophorin A is an example of such severe changes that can possibly occur in the neuron in NeuroAIDS. Glycophorin is a well known component of red blood cell membranes. The RNA that is purified in our procedures is free of all proteins and the detection method used is purely nucleic acid. Moreover, even if glycophorin mRNA were present in mature circulating red blood cells, red blood cells would not be present in our neuronal preparations, because we excise neurons from 10 micron thick sections (ie, smaller than the diameter of these neurons), the neurons are clearly identified with Nissl stain, and are the only cells with nucleoli in these sections. In addition, there were no endothelial cells associated with the neurons because of precision of excision by the laser beam. Likewise, red blood cells would be even further away from the excised neurons and well outside the laser excision perimeter. This greatly reduces the possibility of purifying and amplifying mRNA for glycophorin from red blood cells or any other potentially contaminating cells in our preparations. The glycophorin or glycophorin-like RNA that we detected, in all likelihood, is derived from anomalous glycophorin gene expression in the neurons we analyzed. Also, this is most likely due to the stress undergone by these neurons in their chronic state of disease.
Neurobehavioral
This study is an initial step towards identifying specific genes in neuroanatomically specific neurons that may be involved in neurodegenerative processes that result from HIV-1 infection of the brain. Moreover, a wide range of biochemical processes in the health and maintenance of the cell are dysregulated. Some genes are novel, including for multinetwork detection proteins. This line of investigation is useful and will provide further specific information about dysfunction of gene expression in HAND.
Conclusion
Novel directions in the analysis and categorization of the transcriptome in disease and health are under development for HAND. For example, systems biological approaches are being developed to elucidate transcriptome organization patterns that are highly correlated across samples and that identify groups of genes or modules. 51 In addition, future prospective studies should be designed to answer additional questions, for example, related to virus load, symptomatology, as well as comparisons across the different stages in the evolution of diagnostic criteria for NeuroAIDS. It will also be of use to validate the data with additional patient cohorts.
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